FDA Investigator: Jeffrey S. Buckser
- Jeffrey S. Buckser first started conducting FDA inspections in 2003, with the last inspection in 2023. Over that time, Jeffrey S. Buckser has conducted 68 inspections at 63 companies across 62 sites.
Get Jeffrey Buckser's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 North Coast Medical, Morgan Hill | August 2023
Available Now - $199
Jeffrey S. Buckser
Medical Devices & Rad Health Form 483
FDA 483 Phoenix Deventures, Morgan Hill | February 2023
Available Now - $199
Jeffrey S. Buckser
Medical Devices & Rad Health Form 483
FDA 483 Embolx, Sunnyvale | January 2023
Available Now - $199
Jeffrey S. Buckser
Medical Devices & Rad Health Form 483
FDA 483 Jazz Imaging, San Jose | October 2022
Available Now - $199
Jeffrey S. Buckser
Medical Devices & Rad Health Form 483
FDA 483 Intuitive Surgical, Sunnyvale | August 2021
Available Now - $199
Jeffrey S. Buckser
Medical Devices & Rad Health Form 483
FDA 483 Cardiva Medical, Inc., Santa Clara | 2023
Out-of-stock
Jeffrey S. Buckser
Medical Devices & Rad Health Form 483
FDA 483 LASERNEEDLE GMBH, Berlin | 2023
Out-of-stock
Jeffrey S. Buckser
Medical Devices & Rad Health Form 483
FDA 483 INTER MEDICAL MEDIZINTECHNIK GMBH, Lubbecke | 2023
Out-of-stock
Jeffrey S. Buckser
Medical Devices & Rad Health Form 483
FDA 483 MELOQ AB, Stockholm | 2023
Out-of-stock
Jeffrey S. Buckser
Medical Devices & Rad Health Form 483
Co-Investigators (13)
- Juanj Wu, FDA Investigator
- Maida Henesian, FDA Investigator
- Christopher W. Buser, FDA Investigator
- Eileen M. Malecki, FDA Investigator
- Eric J. Heinze, FDA Investigator
- Harjap K. Atwal, FDA Investigator
- Hien Albright, FDA Investigator
- Thomas Cote, FDA Investigator
- Richard L. Licari, FDA Investigator
- Seth A. Mailhot, FDA Investigator
- Elizabeth B. Griffin, FDA Investigator
- Timothy M. Glod, FDA Investigator
- Christopher K. Vantwuyver, FDA Investigator